How to buy Sanofi shares
Own Sanofi shares in just a few minutes.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Sanofi is a drug manufacturers-general business with stocks listed in the US. Sanofi shares (SNY) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$52.43 – a decrease of 1.87% over the previous week. Here's how to invest if you're based in Australia.
How to buy shares in Sanofi
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Sanofi. Find the share by name or ticker symbol: SNY. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Sanofi reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$52.43, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Sanofi, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Sanofi. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Sanofi key stats
- Compare share trading platforms
- Is Sanofi stock a buy or sell?
- Sanofi performance over time
- Can I short Sanofi shares?
- Are Sanofi shares over-valued?
- Sanofi's financials
- How volatile are Sanofi shares?
- Does Sanofi pay a dividend?
- Have Sanofi shares ever split?
- Other common questions
Sanofi share priceUse our graph to track the performance of SNY stocks over time.
Sanofi shares at a glance
|52-week range||US$43.131 - US$54.19|
|50-day moving average||US$52.3931|
|200-day moving average||US$49.5452|
|Dividend yield||US$3.2 (6.15%)|
|Earnings per share (TTM)||US$5.8995|
Compare share trading platforms to buy stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Sanofi stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Sanofi price performance over time
|1 week (2021-06-08)||0.71%|
|1 month (2021-05-14)||-0.59%|
|3 months (2021-03-15)||7.64%|
|6 months (2020-12-15)||13.28%|
|1 year (2020-06-15)||3.64%|
|2 years (2019-06-14)||23.45%|
|3 years (2018-06-15)||31.27%|
|5 years (2016-06-15)||37.36%|
Is Sanofi under- or over-valued?
Valuing Sanofi stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sanofi's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Sanofi's P/E ratio
Sanofi's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Sanofi shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Sanofi's PEG ratio
Sanofi's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.0951. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Sanofi's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Sanofi's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$10.6 billion.
The EBITDA is a measure of a Sanofi's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||US$36.9 billion|
|Operating margin TTM||21.1%|
|Gross profit TTM||US$25.3 billion|
|Return on assets TTM||4.19%|
|Return on equity TTM||20.01%|
|Market capitalisation||US$131.7 billion|
TTM: trailing 12 months
Shorting Sanofi shares
There are currently 4.6 million Sanofi shares held short by investors – that's known as Sanofi's "short interest". This figure is 1.6% up from 4.5 million last month.
There are a few different ways that this level of interest in shorting Sanofi shares can be evaluated.
Sanofi's "short interest ratio" (SIR)
Sanofi's "short interest ratio" (SIR) is the quantity of Sanofi shares currently shorted divided by the average quantity of Sanofi shares traded daily (recently around 1.4 million). Sanofi's SIR currently stands at 3.33. In other words for every 100,000 Sanofi shares traded daily on the market, roughly 3330 shares are currently held short.
However Sanofi's short interest can also be evaluated against the total number of Sanofi shares, or, against the total number of tradable Sanofi shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sanofi's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Sanofi shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Sanofi shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Sanofi.
Find out more about how you can short Sanofi stock.
Sanofi share dividends
Dividend payout ratio: 53.97% of net profits
Recently Sanofi has paid out, on average, around 53.97% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.7% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Sanofi shareholders could enjoy a 3.7% return on their shares, in the form of dividend payments. In Sanofi's case, that would currently equate to about $3.2 per share.
Sanofi's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Sanofi's most recent dividend payout was on 25 May 2021. The latest dividend was paid out to all shareholders who bought their shares by 2 May 2021 (the "ex-dividend date").
Have Sanofi's shares ever split?
Sanofi's shares were split on a 5:1 basis on 29 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Sanofi shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Sanofi shares which in turn could have impacted Sanofi's share price.
Sanofi share price volatility
Over the last 12 months, Sanofi's shares have ranged in value from as little as US$43.131 up to US$54.19. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sanofi's is 0.3952. This would suggest that Sanofi's shares are less volatile than average (for this exchange).
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration with TrialSpark Inc. to execute clinical research studies in the areas of chronic obstructive pulmonary disease. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Frequently asked questions
More guides on Finder
Your first look at the Billie Eilish x Air Jordan 1 sneaker collab
Featuring Billie's signature shade, here's what you need to know if you want to cop these kicks.
Amazon Prime Day 2021: Don’t miss these deals on 21 June
Amazon Prime Day is returning to Australia in the first half of 2021. Here are six online deals you need to know about.
How to buy TitanSwap (TITAN) in Australia
This guide will show you step-by-step instructions on how to buy the TitanSwap (TITAN) token as well as a list of exchanges you can trade it on.
Canterbury Bulldogs vs St George Illawarra Dragons NRL: Start time and watch free
The one-win Bulldogs return after a bye, hopefully refreshed and ready to meet the Dragons.
NSW first home owners tax reform offers 25K grants
First home buyers in NSW could be given up to $25,000 towards their first home purchase – find out if you're eligible.
24 PlayStation 5 consoles are up for grabs this long weekend
eBay is giving away 24 PlayStation 5 prize packs this long weekend - here's how to enter.
Does anyone actually need Twitter Blue?
Here's everything included in Twitter Blue and how much it costs.
How to watch UFC 263 Adesanya vs Vettori 2 live in Australia
Undisputed champion Israel Adesanya is ready for his long-awaited rematch against Marvin Vettori in Arizona.
HBO Max Gossip Girl reboot: new trailer drops ahead of Australian broadcast
An updated version of Gossip Girl is coming our way – and it looks too good to miss.
Finder Daily Deals: The 5 best online deals in Australia today
Today's best Finder Daily deals include: 50% off 4K TVs, $200 off Dyson vacuum cleaners, win $10,000 with Optus.
Ask an Expert